Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1
索拉非尼诱发的皮肤肿瘤;矛盾的 RAS-RAF 通路激活以及 HRAS、TP53 和 TGFBR1 的致癌突变
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-11-1344
Jean Philippe Arnault, Christine Mateus, Bernard Escudier, Gorana Tomasic, Janine Wechsler, Emilie Hollville, Jean-Charles Soria, David Malka, Alain Sarasin, Magalie Larcher, Jocelyne André, Nyam Kamsu-Kom, Lise Boussemart, Ludovic Lacroix, Alain Spatz, Alexander M Eggermont, Sabine Druillennec, Ste